Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study.

Hassoun, Ahmed Ak; Pathan, Md Faruque; Medlej, Rita C; Alarouj, Monira; Shaltout, Inass; Chawla, Manoj S; Knap, Ditte; Vaz, Julius A

Hassoun, Ahmed Ak; Pathan, Md Faruque; Medlej, Rita C; Alarouj, Monira; Shaltout, Inass; Chawla, Manoj S; Knap, Ditte; Vaz, Julius A.

Afiliación

Hassoun AA; Dubai Diabetes Centre, Dubai, UAE.
Pathan MF; Department of Endocrinology, BIRDEM Hospital, Dhaka, Bangladesh.
Medlej RC; Department of Endocrinology, Hotel Dieu de France Hospital; Chronic Care Centre, Saint Joseph University, Beirut, Lebanon.
Alarouj M; Dasman Diabetes Institute, Dasman, Kuwait.
Shaltout I; Faculty of Medicine, Cairo University, Cairo, Egypt.
Chawla MS; Lina Diabetes Care Centre, Mumbai, India.
Knap D; Novartis Pharma AG, Basel, Switzerland.
Vaz JA; Novartis Healthcare Private Limited, Hyderabad, India.

Diabetes Metab Syndr Obes ; 9: 225-31, 2016.

Article en En | MEDLINE | ID: mdl-27555791

Palabras clave

Ramadan; age; metformin; sulfonylurea; type 2 diabetes; vildagliptin

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Diabetes Metab Syndr Obes Año: 2016 Tipo del documento: Article Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google